- Home
- XNCR vs BFS Comparison
XNCR vs BFS Comparison
Compare XNCR & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | BFS |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 902.2M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | XNCR | BFS |
|---|---|---|
| Price | $19.84 | $33.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $22.33 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.0M | 75.8K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 6.92% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | $4.80 | $5.67 |
| P/E Ratio | ★ N/A | $30.48 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $29.16 |
| 52 Week High | $21.76 | $38.42 |
Technical Indicators
Market Signals| Indicator | XNCR | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 62.00 | 32.26 |
| Support Level | $11.20 | $32.56 |
| Resistance Level | $21.26 | $34.99 |
| Average True Range (ATR) | 1.59 | 0.77 |
| MACD | -0.07 | -0.24 |
| Stochastic Oscillator | 73.60 | 10.10 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.